BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2465745)

  • 1. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS; Nosik DN; Novokhatskiĭ AS; Trushinskaia GN
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
    Adolf GR
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH; Kelley S; Chiu H; Stebbing N
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are the acid-labile interferon alpha and interferon omega-1 identical?
    Kontsek P; Borecký L; Novák M
    Virology; 1991 Mar; 181(1):416-8. PubMed ID: 1994590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the biological properties of plasmid and natural human interferons].
    Ovchinnikov IuA; Zhdanov VM; Solov'ev VD; Novokhatskiĭ AS; Aspetov RD
    Vopr Virusol; 1983; 28(1):14-21. PubMed ID: 6189294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN; Grossberg SE
    J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some biological activities of rabbit anti-interferon serum.
    Fuchsberger N; Styk B; Borecký L; Hajnická V
    Acta Virol; 1976 Apr; 20(2):107-13. PubMed ID: 5864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
    J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Simple method of determining the antiproliferative activity of human interferons].
    Aspetov RD; Shaĭkhinova TB; Novokhatskiĭ AS; Shuratov IKh
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):204-8. PubMed ID: 2409914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reaction of the anti-interferon-alpha monoclonal antibody, NK2, with different interferons.
    Whittall JT; King RM; Burke DC
    J Gen Virol; 1984 Mar; 65 ( Pt 3)():629-33. PubMed ID: 6199457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel modified beta-interferons: gene cloning, expression, and biological activity in bacterial extracts.
    Porter AG; Bell LD; Adair J; Catlin GH; Clarke J; Davies JA; Dawson K; Derbyshire R; Doel SM; Dunthorne L
    DNA; 1986 Apr; 5(2):137-48. PubMed ID: 3519136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T; Parti S; Barwick S; Meager A
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitoxic activity of interferon preparations].
    Zueva VS; Pashutin SB; Kuznetsov VP; Spivak NIa; Korobko IV
    Antibiot Med Biotekhnol; 1985 Sep; 30(9):665-8. PubMed ID: 2415059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physicochemical and biological properties of human placental amniotic interferon].
    Bakhutashvili VI; Merabishvili DG; Gogitashvili RV; Korsantiia BM; Dzotsenidze LL
    Vopr Virusol; 1985; 30(6):693-7. PubMed ID: 2420070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
    Karayianni-Vasconcelos G; Borecký L; Kontsek P
    Vet Immunol Immunopathol; 1993 Oct; 38(3-4):359-65. PubMed ID: 7507275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G; Currenti M; Turriziani O; Dianzani F
    J Infect Dis; 1991 Apr; 163(4):882-5. PubMed ID: 1901335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.